New drug combination for advanced breast cancer delays disease progression

A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The drug combination doubled the number of patients whose cancer had not progressed after one year from 14% to 28%, according to the study.

Read the whole article on Science Daily

More from Science Daily